Financing
Payment of Deferred Purchase Consideration
Gilead Sciences Payment of Deferred Purchase Consideration decreased by 184.1% to -$179.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.7%, from -$176.00M to -$179.00M. Over 4 years (FY 2021 to FY 2025), Payment of Deferred Purchase Consideration shows a downward trend with a 32.0% CAGR.
Analysis
StatementCash Flow Statement
SectionFinancing
First reportedQ1 2015
Last reportedQ1 2026May 7, 2026
Metric ID:
isrg_payment_of_deferred_purchase_considerationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$6.00M | -$39.00M | -$11.00M | -$91.00M | -$14.00M | -$45.00M | -$23.00M | -$135.00M | -$32.00M | -$78.00M | -$34.00M | -$116.00M | -$36.00M | -$82.00M | -$47.00M | -$176.00M | -$64.00M | -$137.00M | -$63.00M | -$179.00M |
| QoQ Change | — | -550.0% | +71.8% | -727.3% | +84.6% | -221.4% | +48.9% | -487.0% | +76.3% | -143.8% | +56.4% | -241.2% | +69.0% | -127.8% | +42.7% | -274.5% | +63.6% | -114.1% | +54.0% | -184.1% |
| YoY Change | — | — | — | — | -133.3% | -15.4% | -109.1% | -48.4% | -128.6% | -73.3% | -47.8% | +14.1% | -12.5% | -5.1% | -38.2% | -51.7% | -77.8% | -67.1% | -34.0% | -1.7% |
Range-$179.00M – -$6.00M
CAGR+104.4%
Avg YoY Growth-51.9%
Median YoY Growth-48.1%
Payment of Deferred Purchase Consideration at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's payment of deferred purchase consideration?
- Gilead Sciences (GILD) reported payment of deferred purchase consideration of -$179.00M in Q1 2026.
- How has Gilead Sciences's payment of deferred purchase consideration changed year-over-year?
- Gilead Sciences's payment of deferred purchase consideration decreased by 1.7% year-over-year, from -$176.00M to -$179.00M.
- What is the long-term trend for Gilead Sciences's payment of deferred purchase consideration?
- Over 4 years (2021 to 2025), Gilead Sciences's payment of deferred purchase consideration has grown at a 32.0% compound annual growth rate (CAGR), from -$145.00M to -$440.00M.